During the past decade, Rotterdam Eye Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rotterdam Eye Hospital" #1 sponsor was "Glaukos Corporation" with 2 trials, followed by "QLT Inc." with 2 trials sponsored, "Erasmus Medical Center" with 1 trials sponsored, "Ionis Pharmaceuticals, Inc." with 1 trials sponsored and "Maastricht University Medical Center" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rotterdam Eye Hospital" #1 collaborator was "Leiden University Medical Center" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Amsterdam UMC, location AMC" with 1 trials as a collaborator, "Dr. F.P. Fischer-stichting, Utrecht, The Netherlands" with 1 trials as a collaborator and "Free University Medical Center" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Rotterdam Eye Hospital" are "LCA (Leber Congenital Amaurosis)" (2 trials), "Open-Angle Glaucoma" (2 trials), "RP (Retinitis Pigmentosa)" (2 trials), "Astigmatism" (1 trials) and "Chronic Central Serous Chorioretinopathy" (1 trials). Many other conditions were trialed in "Rotterdam Eye Hospital" in a lesser frequency.

Most popular intervention types in "Rotterdam Eye Hospital" are "Drug" (6 trials), "Device" (3 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Glaucoma Surgery" (2 trials), "Placebo" (2 trials), "QLT091001" (2 trials), "AcrySof Monofocal IOL, model SN60AT" (1 trials) and "AcrySof Toric intraocular lens, model SN60TT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rotterdam Eye Hospital" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Rotterdam Eye Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Rotterdam Eye Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rotterdam Eye Hospital, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".